Oncotarget

August 18, 2020

View Archive »

About The Cover

The cover for issue 33 of Oncotarget features Figure 8, "Haplotype estimates in follicular lymphoma patients," by Assis-Mendonça, et al.

Table of Contents

Research Papers

A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer

A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer

https://doi.org/10.18632/oncotarget.27684

Simona Ruxandra Volovat, Tudor-Eliade Ciuleanu, Piotr Koralewski, Juneko E. Grilley Olson, Adina Croitoru, Krassimir Koynov, Stefano Stabile, Giulio Cerea, Atsushi Osada, Iulian Bobe,  and Constantin Volovat
3105-3117
Abstract  |  PDF  |  Full Text  |  How to cite

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases

https://doi.org/10.18632/oncotarget.27686

Gino K. In, Kelsey Poorman, Michelle Saul, Steven O’Day, Jeffrey M. Farma, Anthony J. Olszanski, Michael S. Gordon, Jacob S. Thomas, Burton Eisenberg, Lawrence Flaherty, Amy Weise, Steven Daveluy, Geoffrey Gibney, Michael B. Atkins,  and Ari Vanderwalde
3118-3128
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Carnosic acid increases sorafenib-induced inhibition of ERK1/2 and STAT3 signaling which contributes to reduced cell proliferation and survival of hepatocellular carcinoma cells

Carnosic acid increases sorafenib-induced inhibition of ERK1/2 and STAT3 signaling which contributes to reduced cell proliferation and survival of hepatocellular carcinoma cells

https://doi.org/10.18632/oncotarget.27687

Xuening Wang, Priya Gupta, Yasmeen Jramne, Michael Danilenko, Dongfang Liu,  and George P. Studzinski
3129-3143
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Superior prognosis stratification for stage III colon cancer using log odds of positive lymph nodes (LODDS) compared to TNM stage classification: the Japanese study group for postoperative follow-up of colorectal cancer

Superior prognosis stratification for stage III colon cancer using log odds of positive lymph nodes (LODDS) compared to TNM stage classification: the Japanese study group for postoperative follow-up of colorectal cancer

https://doi.org/10.18632/oncotarget.27692

Shimpei Ogawa, Michio Itabashi, Yoshiko Bamba, Masakazu Yamamoto,  and Kenichi Sugihara
3144-3152
Abstract  |  PDF  |  Full Text  |  How to cite

An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course

An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course

https://doi.org/10.18632/oncotarget.27698

Guilherme Rossi Assis-Mendonça, André Fattori, Rafael Malagoli Rocha, Gustavo Jacob Lourenço, Márcia Torresan Delamain, Suely Nonogaki, Vladmir Cláudio Cordeiro de Lima, Gisele Wally Braga Colleoni, Cármino Antonio de Souza, Fernando Augusto Soares, Carmen Silvia Passos Lima,  and José Vassallo
3153-3173
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release

The bromodomain inhibitor IBET-151 attenuates vismodegib-resistant esophageal adenocarcinoma growth through reduction of GLI signaling

The bromodomain inhibitor IBET-151 attenuates vismodegib-resistant esophageal adenocarcinoma growth through reduction of GLI signaling

https://doi.org/10.18632/oncotarget.27699

Annamil Alvarez-Trotta, Zhiqiang Wang, Elena Shersher, Bin Li, Jun Long, Ines Lohse, Claes Wahlestedt, Wael El-Rifai, David J. Robbins,  and Anthony J. Capobianco
3174-3187
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite


Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC